United states

Novo Nordisk Stock Skids After Eli Lilly Wins In Head-To-Head Study Pitting Weight-Loss Drugs – Investor's Business Daily

November 28, 2023
0 Views
1 Min Read
  1. Novo Nordisk Stock Skids After Eli Lilly Wins In Head-To-Head Study Pitting Weight-Loss Drugs  Investor’s Business Daily
  2. Mounjaro may be 3 times more effective than Ozempic, study finds  TODAY
  3. Eli Lilly (NYSE:LLY) Pops Up after Beating Novo Nordisk in Weight Loss – TipRanks.com  TipRanks
  4. Eli Lily’s Mounjaro is more effective for weight loss than Ozempic, study shows  Fox Business
  5. Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis  Medpage Today

Add Comment

Click here to post a comment